Evolve® PTCA Balloon Catheter — Hybrid Dilation Technology The Evolve® balloon dilation catheter by Swiss manufacturer IHT SA (Grupo IHT) is a high-performance RX (Rapid Exchange) device for coronary angioplasty (PTCA). Its unique feature is the "dual compliance" behavior, making it a versatile tool for interventional cardiologists. Key Benefits: Hybrid Compliance: functions as a semi-compliant (SC) balloon at low pressures for lesion preparation and transitions to a non-compliant (NC) behavior at high pressures for precise post-dilation. Versatility: a single device replaces two, allowing for both pre-dilation and final stent optimization. Swiss Precision: the design ensures excellent crossability and deliverability into challenging anatomical zones. Safety: high pressure resistance minimizes the risk of balloon rupture during aggressive interventions.
IHT Central Asia LLP is a Kazakh-Spanish joint venture and the only manufacturer of coronary stents and balloon catheters in Central Asia, established in 2023. The company produces high-tech interventional cardiology devices based on European technology transfer. Production is localized in Astana and focused on treating ischemic heart disease and preventing myocardial infarction. Product range: Drug-eluting coronary stents (DEStiny) Balloon catheters for angioplasty (Evolve) Solutions for percutaneous coronary interventions Key advantages: Unique regional manufacturer Proven European technology and clinical validation Coverage of Kazakhstan demand (up to 36,000 stents/year) Up to 30% lower cost than imports Export to Central Asia and other markets IHT Central Asia delivers advanced cardiovascular solutions focused on technology, accessibility, and reliability for healthcare systems.
